Skip to main content
Premium Trial:

Request an Annual Quote

TGen Spurs Software Firm to Open in Phoenix

NEW YORK, June 26 - Life sciences software firm 5AM Solutions has opened its doors in Phoenix to be near the Translational Genomics Research Institute, the firm and TGen said today.

 

5AM is headed up by Brent Gendleman (CEO) and Rob Daly (COO), who recently relocated to Phoenix from the Washington, DC area.

 

The firm is currently working on TGen's bioinformatics facility, as well as a data collection system for a national microarray consortium. Dietrick Stephan, director of the TGen Neurogenomics Division, is overseeing this national microarray consortium project, which is funded by NIMH and NINDS.

 

"Everyone who helped establish TGen hoped the institute would bring new businesses to Arizona.  Now we see that expectation was accurate," said Richard Love, TGen's COO, in a statement.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.